Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Treatment Patterns of Severe Asthmatic Patients Across the Gulf Region - SevEos Study SevEos is a Cross-sectional, Multi-center, Non-interventional Study Aimed to Describe the Treatment Patterns in 250 Severe Asthma Patients Across the Gulf Region.

NCT03387722 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT03387722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03387722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Treatment Patterns of Severe Asthmatic Patients Across the Gulf Region - SevEos Study SevEos is a Cross-sectional, Multi-center, Non-interventional Study Aimed to Describe the Treatment Patterns in 250 Severe Asthma Patients Across the Gulf Region.
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
December 31, 2017
Completion date
January 3, 2019
Enrollment
253 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

severe asthma